- Home
- TNGX vs FSLY Comparison
TNGX vs FSLY Comparison
Compare TNGX & FSLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNGX | FSLY |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.5B |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | TNGX | FSLY |
|---|---|---|
| Price | $21.57 | $33.27 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 7 |
| Target Price | ★ $20.00 | $13.00 |
| AVG Volume (30 Days) | 3.7M | ★ 10.8M |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 26.89 | ★ 27.19 |
| EPS | N/A | ★ N/A |
| Revenue | $62,384,000.00 | ★ $624,018,000.00 |
| Revenue This Year | N/A | $16.43 |
| Revenue Next Year | N/A | $10.45 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 48.29 | 14.78 |
| 52 Week Low | $1.04 | $4.65 |
| 52 Week High | $22.20 | $34.22 |
Technical Indicators
Market Signals| Indicator | TNGX | FSLY |
|---|---|---|
| Relative Strength Index (RSI) | 74.32 | 72.19 |
| Support Level | $5.98 | $7.89 |
| Resistance Level | $21.82 | N/A |
| Average True Range (ATR) | 1.24 | 2.82 |
| MACD | 0.08 | 0.24 |
| Stochastic Oscillator | 90.10 | 94.03 |
Price Performance
Historical ComparisonAbout TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About FSLY Fastly Inc.
Fastly Inc is a cloud computing company that provides an edge cloud platform designed to deliver, secure, and optimize digital experiences over the internet. The company operates a unified platform that combines content delivery, edge computing, and security capabilities. Its services include content delivery networks, web and API protection, distributed denial of service mitigation, and real-time data processing at the edge. Its platform enables customers to improve the performance, scalability, and security of applications and digital content, and also supports cloud-native architectures, AI-driven workloads, and programmable edge computing solutions.